IL6 and non-small cell lung carcinoma: Taken together, our findings were summarized in a model (Figure 7K) to propose that Gankyrin promotes EMT and metastasis in NSCLC through forming a closed circle with IL-6/p-STAT3 and TGF-β/p-SMAD3 signal pathway.